Farrow Jeffrey S — SEC Form 4 filings
SEC reporting owner CIK 1405253. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-11 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 5 filings — 48,603 shares, $2,332,268 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 14,396 shares @ $60.95 ($877,436) in Tarsus Pharmaceuticals, Inc., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | See Remarks | 10 | — | 9 legs · 48,603 sh · $2,332,268 | 17 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | Director | 2 | — | — | 3 |
Form 4 filings — Farrow Jeffrey S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 16,700 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 27,881 · Sale (S): 14,396 @ $60.95 · Option exercise (M): 27,881 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/award (A): 47,250 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 2,111 @ $69.42 · Sale (S): 2,133 @ $68.71 · Sale (S): 2,186 @ $67 | EDGAR |
| 2026-03-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 13,042 · Option exercise (M): 8,020 (derivative) @ $0 · Option exercise (M): 5,022 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 30,724 (derivative) @ $0 · Grant/award (A): 19,306 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 27,881 · Sale (S): 13,608 @ $40.42 · Option exercise (M): 27,881 (derivative) @ $0 | EDGAR |
| 2025-03-20 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 1,284 @ $46.29 · Sale (S): 1,254 @ $47.40 · Sale (S): 1,186 @ $50.11 | EDGAR |
| 2025-03-18 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 8,019 · Option exercise (M): 8,019 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 30,628 (derivative) @ $0 · Grant/award (A): 20,089 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 27,881 · Sale (S): 10,445 @ $27.47 · Option exercise (M): 27,881 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 47,500 (derivative) @ $0 · Grant/award (A): 32,079 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1405253 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →